Risk factors for venous thromboembolism in patients with chronic liver disease;Factores de riesgo para tromboembolismo en pacientes con enfermedad crónica del hígado

Annals of Pharmacotherapy

Volumn 47, Issue 3, 2013, Pages 333-339

  Walsh, Kelly A ^a,b   Lewis, Daniel A ^a,c   Clifford, Timothy M ^d   Hundley, Jonathan C ^d   Gokun, Yevgeniya ^e   Angulo, Paul ^d   Davis, George A ^d  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

^c South Pointe Hospital   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE CONTROL STUDY; CHRONIC LIVER DISEASE; DISEASE ASSOCIATION; FEMALE; HEMATOCRIT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ALANINE TRANSAMINASE; ALBUMINS; ASPARTATE AMINOTRANSFERASES; HEMATOCRIT; HUMANS; LIVER DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84875171960     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R496     Document Type: Article

References (27)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. on behalf of the American Heart Association Heart Disease Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2011 update: a report from the American Heart Association. Circulation 2011;123:e18-e209.
2. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med 2010;38:S495-501.
3. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th edition: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012;141(2 suppl):e195S-226S.
4. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365:147-56.
5. Dabbagh O, Oza A, Prakash S, Sunna R, Saettele TM. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest 2010;137:1145-9.
6. Northup PG, McMahan MM, Ruhl AP, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006;101:1524-8.
7. Gulley DG, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 2008;53:3012-7.
8. Garcia-Fuster MJ, Abdilla N, Fabia MJ, Fernandez C, Oliver V, Forner MJ. Venous thromboembolism and liver cirrhosis. Rev Esp Enferm Dig 2008:100:159-62.
9. Ali M, Ananthakrishnan AN, McGinley EL, Saeian K. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci 2011;56:2152-9.
10. Lizarraga WA, Dalia S, Reinert SE, Schiffman FJ. Venous thrombosis in patients with chronic liver disease. Blood Coagul Fibrinolysis 2010;21:431-5.
11. Soogard KK, Horvath-Puho E, Gronback H, Jepsen P, Vilstrup H, Sorensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009;104:96-101.
12. Wu H, Nguyen GC. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol 2010;8:800-5.
13. Aldawood A, Arabi Y, Aljumah A, et al. The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J 2011;9:1-6.
14. Lesmana CR, Inggriani S, Cahyadinata L, Lesmana LA. Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int 2010;4:433-8.
15. Saleh T, Matta F, Alali F, Stein P. Venous thromboembolism with chronic liver disease. Am J Med 2011;124:64-8.
16. Koliscak L, Maynor L. Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies. Am J Health Syst Pharm 2012;69:658-63.
17. Pincus KJ, Tata AL, Watson K. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis. Ann Pharmacother 2012;46:873-8. doi: 10.1345/aph.1Q726
18. Northup PG. Hypercoagulation in liver disease. Clin Liver Dis 2009;13: 109-16.
19. Lisman T, Bongers TN, Adelmeijer J, et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006;44:53-61.
20. Afdhal N, McHutchison J, Brown R, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol 2008;48:1000-7.
21. Tripodi A, Primignani M, Chantarangkul V, et al. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 2006;44:440-5.
22. Oka K, Tanaka K. Intravascular coagulation in autopsy cases with liver disease. Thromb Haemost 1979;42:564-70.
23. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995;21: 1238-47.
24. Tufano A, Guida A, DiMinno MN, Prisco D, Cerbone AM, DiMinno G. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. Semin Thromb Hemost 2011;37:267-74.
25. Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford) 2009; 11:459-64.
26. Northup PG, Caldwell SH. Coagulation disorders in cirrhosis-time for a new clinical paradigm? US Gastroenterol Hepatol Rev 2007;2:55-6.
27. McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991;31:164-71.